Purpose Photoacoustic tomography can image the hemoglobin distribution and oxygenation state inside tissue with high spatial resolution. The purpose of this study is to investigate its clinical usefulness for diagnosis of breast cancer and evaluation of therapeutic response in relation to other diagnostic modalities. Materials and methods Using a prototype machine for photoacoustic mammography (PAM), 27 breast tumor lesions, including 21 invasive breast cancer (IBC), five ductal carcinoma in situ (DCIS), and one phyllodes tumor, were measured. Nine out of twenty-one IBC patients had received primary systemic therapy (PST). Results Eight out of twelve IBC without PST were visible. Notably, detection was possible in all five cases with DCIS, whereas it was not in one case with phyllodes tumor. Seven out of nine IBC with PST were assigned as visible in spite of decreased size of tumor after PST. The mean value of hemoglobin saturation in the visible lesions was 78.6 %, and hemoglobin concentration was 207 lM. The tumor images of PAM were comparable to those of magnetic resonance imaging (MRI). Conclusions It is suggested that PAM can image tumor vascularity and oxygenation, which may be useful for diagnosis and characterization of breast cancer.
Introduction
Breast cancer is one of the most common malignant diseases in women. Early detection and diagnosis are essential to decrease mortality. In addition, as the number of cases of primary systemic therapy (PST) increases, efforts have been made to develop a sensitive method for monitoring treatment effect [1] [2] [3] . Conventional diagnostic modalities, including X-ray mammography (MMG), ultrasonography (US), and magnetic resonance imaging (MRI), are useful for these purposes, but each has some drawbacks. Mammography is associated with ionizing radiation and has diagnostic weakness for dense breast. The results of ultrasound greatly depend on the instrumental performance and examiner's skill. MRI requires use of contrast medium, which is not suitable for mass screening and repeated examination.
Optical detection of breast cancer using near-infrared (NIR) light has drawn much attention because it can measure the hemoglobin distribution and oxygenation state inside the tissue noninvasively [4, 5] . Angiogenesis is essential for breast cancer growth and also correlates with the malignant potential of precursor lesion [6] [7] [8] [9] . It is known that microvessel density in cancer tissue significantly decreases in responders to PST from the early period [10] . Therefore, optical imaging has great potential as the basis for novel diagnostic modalities for breast cancer. Several studies have reported promising results for diffuse optical tomography (DOT) used for differential diagnosis and therapeutic monitoring of breast cancer [11] [12] [13] [14] [15] [16] [17] . However, at present, its clinical usefulness seems to be limited due to poor spatial resolution. Photoacoustic tomography is another modality of optical imaging based on photoacoustic technology, enabling imaging of the hemoglobin distribution and oxygenation state inside tissue with higher spatial resolution than DOT [18] [19] [20] . There are a few preliminary reports on such approaches for breast cancer [21] [22] [23] .
In this paper, we report early results of clinical application of photoacoustic mammography (PAM) and investigate its usefulness for diagnosis of breast cancer and evaluation of therapeutic response in relation to other diagnostic modalities.
Materials and methods

Instruments
A prototype machine of a dual illuminated mode photoacoustic tomography system (Canon Inc., Tokyo, Japan) was used [24, 25] . Figure 1 shows a photograph of the machine and a schematic of the measurement. The patient-instrument interface was a sliding bed with a 17 cm 9 18 cm hole, which was mounted on a frame housing the laser-emitting and ultrasound detection units. The patient lies in prone position on the bed with her breast placed in the hole. The breast is mildly compressed in craniocaudal direction between holding plates. Acoustic coupling gel is used between the breast and the holding plate that carries the scanning system. Pulsed laser beams irradiate the breast from both sides, and photoacoustic signals are detected on the caudal side by an array transducer. The lasers are mounted at the bottom of the bed and coupled to the scanning system. A Ti:Sa laser optically pumped with a Q-switched Nd:YAG laser is used, having a tunable wavelength in the range 700-900 nm. The measurable area was 30 mm 9 46 mm for one scan, which took 45 s. In the first 16 cases, the scan was performed at three adjacent areas where the lesion was considered to be located in the diseased breast and one area in the intact breast. In the last 15 cases, the scanning system was automatically moved in an area of 120 mm 9 46 mm. Specific parameters of the PAM were as follows: Photoacoustic image reconstruction was carried out using a modified universal backprojection algorithm. Assuming that the breast consisted of homogeneous tissue with known l a and l s ', the l a values of the absorbers were calculated from the initial pressure rise after the laser pulse using the equation shown below [4] . The light fluence distribution inside the breast was estimated using the published data of absorption and scattering coefficients (l a and l s ') of the breast corresponding to the patient's age [26] .
where p 0 is the initial pressure after the laser pulse and C is the Grueneisen parameter; at body temperature, C = 0.20. g th is the percentage that is converted to heat, l a is the absorption coefficient, and F is the light fluence Thus, the distribution of l a in the breast can be calculated from the initial pressure distribution at each wavelength. The oxygen saturation of hemoglobin (SO 2 ) and total hemoglobin concentration (THC) of the lesions were calculated using the l a values at 797 and 756 nm. Extinction coefficients of oxyhemoglobin and deoxyhemoglobin of 0.231 and 0.259 at 797 nm, and 0.163 and 0.511 at 756 nm, respectively, were used.
Patients
Thirty-one patients who were histologically diagnosed with breast cancer or phyllodes tumor were recruited in this study at Kyoto University Hospital from August 2010 to July 2011. Twenty-seven breast lesions of twenty-six cases were subjected to analysis. The other five cases were excluded from analysis because the tumor was outside the measurable area of PAM as the breast was too small or the tumor was located very near to chest wall. MMG, US, and MRI were undertaken as routine preoperative workup. All patients underwent breast surgeries following PAM measurements within 1 month, and no anticancer treatment was given during the interval. The excised specimens were pathologically examined. For assignment of the pathological effect of PST, the Histopathological Criteria for Assessment of Therapeutic Response of the Japanese Breast Cancer Society were used [27] , which assign the pathological effect as grade 0 (no response) to grade 3 (complete response). Visibility of PAM imaging was assigned by one of the authors who is a radiologist specialized in diagnosis of breast cancer. Our procedures were as follows: Signals which were supposed to come from vascular-rich lesions or vessels were extracted from PAM images without considering clinical data including other imaging modalities. The selection criteria were the intensity and morphology of the signal. Linear, winding, or branched shaped signals were attributed to vessels. Grouped or locally scattered signals were attributed to the vascular-rich lesion. Usually, several signals or groups were extracted from one breast measurement. Each PAM signal was then correlated with that of MRI by comparing the locations. The assignment of the location was adjusted by the shape of subcutaneous veins which were demonstrated by both PAM and MRI. When any signal was found to be located at the site of the known tumor, the radiologist judged whether the signal was associated with the tumor, considering the intensity, shape, and distribution.
The study protocol was approved by the Medical Ethical Committee of Kyoto University.
Results
The average age was 58.0 years (36-83 years), and the tumor size measured by MRI was 20.1 mm (11-70 mm). Preoperative diagnosis was invasive breast cancer (IBC) in twenty-one breasts, including twenty invasive ductal carcinomas (IDC), one invasive lobular carcinoma (ILC), ductal carcinoma in situ (DCIS) in five cases, and phyllodes tumor in one case. Biological subtype of IBC was estrogen receptor (ER)?/human epidermal growth factor receptor 2 (HER2)-in eighteen lesions, ER-/HER2? in two, and ER-/HER2-in one. PST was given in 9 out of 21 IBC patients.
The tumor was assigned as visible by PAM in 20 out of 27 breasts (74 %), as shown in Table 1 . Table 2 presents the results of IBC cases without PST. Eight out of twelve IBC were visible. Table 3 shows the results with PST. Five out of nine cases showed clinical partial response and pathological therapeutic effect better than grade 2 (marked response). Seven cases were assigned as visible in spite of decreased tumor size after PST. Table 4 presents the results of DCIS and phyllodes tumor. Notably, detection was possible in all five cases with DCIS. On the other hand, it was not possible with phyllodes tumor. Mean SO 2 in the visible lesions was 78.6 % (53.7-100 %), and mean THC was 207 lM (87-309 lM).
Two particular cases of IBC with or without PST are now presented in detail. The patient was a 75-year-old woman with left breast cancer. MRI showed a tumor with ring enhancement with diameter of 22 mm. Pathological diagnosis was IDC (ER?/HER2?). At PAM measurement, the breast was compressed to thickness of 58 mm. Figure 2 shows subcutaneous blood vessels by PAM. The value of SO 2 ranged from 92.1 to 98.6 %. Figure 3 shows a maximum-intensity projection (MIP) image of PAM at depth between 7.75 and 11.5 mm, indicating clustered signals aligned in a ring shape and a linear-shaped signal. These signals were comparable to the MRI findings and considered to represent the tumor and the feeding vessel, respectively. Mean values of SO 2 and THC in the areas with these signals were 87.1 % and 112 lM, respectively.
IBC after PST
The patient was a 41-year-old woman with right breast cancer. The tumor was reduced in size from 34 to 22 mm in diameter after 6-month treatment with endocrine therapy. PAM image at depth of 28.25 mm showed signals comparable to those of MRI image (Fig. 4) . Pathological diagnosis was IDC (ER?/HER2-), and the therapeutic effect was assigned as grade 1b (moderate response). Mean values of SO 2 and THC of the two assigned lesions were 74.5 % and 385 lM in area A, and 53.8 % and 307 lM in area B, respectively.
Discussion
Photoacoustic tomography refers to imaging that is based on the photoacoustic effect [4, [18] [19] [20] . When light is emitted into tissue, some of the light is absorbed by the object and partially converted into heat. This heat is then further converted to a pressure rise via thermoelastic expansion. The pressure rise is propagated as an ultrasonic wave, which is detected by ultrasonic transducers and used by a computer to form an image. The purpose of using photoacoustic tomography is to combine the contrast of optical absorption with the spatial resolution of ultrasound for deep imaging of living tissue. Since optical absorption provides biological information about tissue vascularization and oxygenation state, functional imaging regarding tissue oxygenation can be obtained. Previous reports using animal models showed successful results of imaging of lymphovascular structure inside tissue [20, 28, 29] . This technology has already been applied to breast cancer patients [21, 23] , but the clinical evaluation was limited.
We compared PAM images with MRI, since MRI is currently the most accurate imaging method for determining the extent of disease in the breast [30, 31] . As shown in Figs. 3 and 4, the PAM tumor image was comparable to that of MRI, demonstrating rim enhancement. These findings could be attributable to the distribution of higher vascular densities in the peripheral area of cancer. However, the PAM tumor image was not mass-forming as shown by MRI. Discrepancy in the image presentation probably arises from the difference in distribution of contrast materials. Photoacoustic imaging represents the distribution of hemoglobin inside the vessels, whereas MRI imaging presents not only the tumor vessels but also the surrounding stroma where the contrast media is shed out from the vessels. In a preliminary study using animals and excised breast cancer specimens, the PAM signal intensity was correlated with the microvessel density in the tumor tissue (data not shown).
In this study, 20 out of 27 breast cancer lesions were assigned as visible in PAM images. The detection rate seems acceptable, considering the variety of cases in this series. Previous clinical studies reported PAM images of breast cancer corresponding to the findings of MMG or US [21, 23] and detection rate similar to ours [23] , but the patient population was rather homogeneous. This study evaluated PAM images in cases of DCIS and IDC with PST as well. Reasons for failure in unsuccessful cases of IBC without PST were mostly due to small breast size, breast surface deformity, and poor tumor vascularity.
Five cases of DCIS with diameters of 63 and 11 mm were visible by PAM, but phyllodes tumor with diameter of 35 mm was not. These results suggest that PAM may be useful to differentiate malignant lesions from benign ones and also to detect breast cancer at an early stage. It was reported that microvascular density increased at the stage of noninvasive carcinoma [7, 9] . Previous studies of DOT also showed that tissue hemoglobin concentration was a good parameter to differentiate between malignant and benign lesions [15, 17] . High spatial resolution of PAM would be beneficial for detection of small DCIS lesions. Further study is necessary to confirm these hypotheses.
Seven out of nine cases after PST could be detected by PAM in spite of decreased tumor diameter and cellularity. As the number of cases of PST increases, sensitive measures for monitoring therapeutic effect are required [32] [33] [34] [35] . As well as radiological imaging modalities and biological markers of biopsy specimens, promising results have been reported for optical imaging using DOT. It has been reported that hemoglobin concentration decreased during PST before morphological changes appeared and that oxygen saturation transiently increased shortly after the start of PST [12, 16] . Since repeated examinations along the treatment course are necessary, the noninvasiveness of optical imaging is beneficial. In addition, PAM has the possibility to monitor not only changes in hemoglobin in the whole tumor but also changes at higher resolution within the tumor. Quantitative evaluation of tumor images by PAM must be established for the purpose of monitoring the effect of PST.
This study used multiple wavelengths to measure PAM signals to estimate the tumor SO 2 and THC, which was the first attempt of its kind in clinical studies. It has been reported that malignant tumor has higher THC and lower SO 2 than background breast tissue. According to a review paper on DOT [17] , tumor showed THC of 65 ± 34 lM, being 2.0-4.5-fold higher than the background THC. The tumor SO 2 was 66 ± 24 %, which was 0.8-0.82-fold that of the background SO 2 . The values of THC and SO 2 of 207 lM and 78.6 %, respectively, in breast cancer calculated in this study were higher than the reported data of DOT. These discrepancies are partly due to the difference in spatial resolution between the two imaging modalities. Contrast of the tumor arises from the difference of hemoglobin concentration between tumor and normal breast tissues in both PAM and DOT. PAM may select a more confined area where the tissue is more vascular rich and oxygenated than the area defined by DOT. However, there are several problems in quantitative evaluation of SO 2 and THC by PAM: (1) The light distribution in the breast tissue at each wavelength should be known a priori. We used l a and l s ' values reported in past literature to calculate the light distribution, but some deviation from the actual distribution might exist in each case. (2) The direction of the vessels and the shape of absorbers should affect the intensity of PAM signals. (3) Noise occurring at the margin of the breast and the boundaries of the compression plates prevents quantitative measurement of the initial pressure of thermoelastic wave. Noise reduction is essential for quantitative evaluation of optical parameters. Further study is necessary to quantify these optical parameters for clinical use.
Breast compression is an inevitable problem with the present method. We compressed the breast for two reasons: to make contact with the plate carrying the ultrasound detectors and to increase the light fluence rate inside the breast by decreasing the breast thickness. However, compression at high pressure may disturb tissue circulation [36] . Care was taken to apply minimal pressure so as not to change the tissue circulation and oxygenation. In fact, clear demonstration of subcutaneous vasculature and reasonable SO 2 values suggested that the tissue circulation was fairly well maintained.
PAM could provide images of tumor vasculature and oxygenation, which cannot be obtained by MMG or US. However, imaging depth and resolution still require improvement. At present, PAM has an advantage in terms of functional features rather than morphology. The combination of PAM with US, as demonstrated in animal models [24, 25] , would be useful to achieve more comprehensive imaging of breast cancer, where the biological and anatomical aspects can be assessed simultaneously. It is suggested that PAM may be useful for diagnosis and characterization of breast cancer, and its further clinical exploration is promising.
